Amy Fowler begins clinical trial to identify hormone-resistant breast cancer
Amy Fowler, MD, PhD harnesses the power of positron emission tomography (PET) and magnetic resonance imaging (MRI) scans in her new clinical study to improve the precision of early-stage breast cancer treatments prior to surgery.
June 7th, 2024